biomarker-driven therapy

ROCKVILLE, Md. & SHANGHAI, July 20, 2026 AbelZeta Pharma, Inc. has achieved a significant regulatory milestone after the European...

SAN ANTONIO, July 20, 2026 Valion Bio, Inc. has announced a significant clinical development milestone after Sheba Medical Center,...

MUMBAI, India & NAPLES, Fla., July 21, 2026 Lupin Limited has announced the strategic spin-out of two promising clinical-stage...

LYON & CAEN, France, June 22, 2026 Lys Therapeutics has announced a major financing milestone, surpassing €25 million in...

AUSTIN, Texas, June 22, 2026 Genprex, Inc. has announced a significant intellectual property milestone after receiving a Notice of...

SOUTH SAN FRANCISCO, Calif., May 7, 2026 ALX Oncology announced promising new clinical findings showing that its investigational CD47...